Skip to content

COAG - Hemab Therapeutics Holdings, Inc. - AlphaYou

Discover Compare Pricing

Sign in Sign up

Home Smart money Buy calls Analyze

Back to stock searchC

Hemab Therapeutics Holdings, Inc. Common Stock

COAG · NASDAQ

Save to watchlist

Price is syncing

Reported smart-money activity for this stock is still below.

C

COAGHemab Therapeutics Holdings, Inc. Common Stock

Overview

No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.

Key stats

Aug 20

52-wk high: $55.42
52-wk low: $18.00
Prev close: $39.80
Mkt cap: $2.41B
P/B: 5.4x
Profit margin: +0.0%

Smart money

8 funds hold a position and insiders have been net buying.

Real smart money

Funds holding this stock

8 holders

Combined position$222.8M

CI
Citadel
Ken Griffin · Q2 2026 13F
$19.2M
position
EP
ExodusPoint

Earnings

Earnings

Results versus expectations

Documents

Quarterly report10-Q Annual report10-K

Financials

Fundamentals

Is the business strong?

This company is running thin margins.

Net margin: 0.0%
Market cap: $2.4B

Valuation

P/B5.38

Quality

Operating margin0.0%
ROE

Technicals

Technicals

Price structure

No data yet

Technicals sync when verified market data is available. No sample data is shown.

Company

Symbol: COAG
Exchange: NASDAQ
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Market cap: $2.41B

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

See the 12-month consensus target and the buy/hold/sell rating split.

Unlock the full results

Research hubs
About
Editorial policy
Methodology
Source coverage
Corrections

Privacy
Terms
Refunds
Disclaimer

© 2026 AlphaYou. All rights reserved.Not financial advice. Do your own research. Informational data only; past performance does not predict future results.

Op margin

+0.0%

ROE

-47.0%

Michael Gelband · Q2 2026 13F

$8.0M

position

MW

Marshall Wace

Q2 2026 13F

$5.7M

position

5 more holders

Lite opens all of them for $16.50/month, paid yearly.

Unlock all 5 holders

Coverage gaps for COAG

No recent Congress trade
No recent market-voice mention

No earnings history on record for this stock yet.

The next reported quarter will appear here

Next report

What the street expects next

EPS expected

-$0.58

-$0.69 to -$0.48

Revenue expected

$0.00

3 analysts

Estimate drift

0.06

Change in 30 days

-47.0%

ROA-30.1%

Growth